Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioanalytical Systems, Inc. stock logo
BASI
Bioanalytical Systems
$0.25
+0.4%
$18.71
$3.05
$21.08
$2.82M1.92122,925 shs572,125 shs
Brainstorm Cell Therapeutics Inc. stock logo
BCLI
Brainstorm Cell Therapeutics
$1.41
+29.9%
$0.95
$0.46
$1.69
$16.04M0.2320,107 shs211,792 shs
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
$1.32
+1.5%
$1.25
$0.62
$1.75
$44.83M1.8952,333 shs145,638 shs
Modular Medical, Inc. stock logo
MODD
Modular Medical
$3.03
+27.8%
$3.55
$1.72
$30.00
$18.13M0.37105,728 shs751,600 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioanalytical Systems, Inc. stock logo
BASI
Bioanalytical Systems
0.00%0.00%0.00%0.00%-86.58%
Brainstorm Cell Therapeutics Inc. stock logo
BCLI
Brainstorm Cell Therapeutics
+11.32%+37.39%+21.11%+51.93%+73.53%
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
-0.76%+2.36%+5.69%+18.18%+68.83%
Modular Medical, Inc. stock logo
MODD
Modular Medical
-4.82%+18.50%-20.47%-28.83%-89.03%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioanalytical Systems, Inc. stock logo
BASI
Bioanalytical Systems
$0.25
+0.4%
$18.71
$3.05
$21.08
$2.82M1.92122,925 shs572,125 shs
Brainstorm Cell Therapeutics Inc. stock logo
BCLI
Brainstorm Cell Therapeutics
$1.41
+29.9%
$0.95
$0.46
$1.69
$16.04M0.2320,107 shs211,792 shs
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
$1.32
+1.5%
$1.25
$0.62
$1.75
$44.83M1.8952,333 shs145,638 shs
Modular Medical, Inc. stock logo
MODD
Modular Medical
$3.03
+27.8%
$3.55
$1.72
$30.00
$18.13M0.37105,728 shs751,600 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioanalytical Systems, Inc. stock logo
BASI
Bioanalytical Systems
0.00%0.00%0.00%0.00%-86.58%
Brainstorm Cell Therapeutics Inc. stock logo
BCLI
Brainstorm Cell Therapeutics
+11.32%+37.39%+21.11%+51.93%+73.53%
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
-0.76%+2.36%+5.69%+18.18%+68.83%
Modular Medical, Inc. stock logo
MODD
Modular Medical
-4.82%+18.50%-20.47%-28.83%-89.03%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bioanalytical Systems, Inc. stock logo
BASI
Bioanalytical Systems
0.00
N/AN/AN/A
Brainstorm Cell Therapeutics Inc. stock logo
BCLI
Brainstorm Cell Therapeutics
0.00
N/AN/AN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
0.00
N/AN/AN/A
Modular Medical, Inc. stock logo
MODD
Modular Medical
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest BASI, LUNA, MODD, and BCLI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/24/2026
Modular Medical, Inc. stock logo
MODD
Modular Medical
Reiterated RatingSell (E+)
(Data available from 8/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bioanalytical Systems, Inc. stock logo
BASI
Bioanalytical Systems
$60.47M0.05$0.00 per share558.40$0.69 per share0.37
Brainstorm Cell Therapeutics Inc. stock logo
BCLI
Brainstorm Cell Therapeutics
N/AN/AN/AN/A($1.36) per shareN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
$116.61M0.38$0.44 per share3.03N/A
Modular Medical, Inc. stock logo
MODD
Modular Medical
N/AN/AN/AN/A$2.78 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bioanalytical Systems, Inc. stock logo
BASI
Bioanalytical Systems
-$4.68M-$0.35N/A6.34N/A-7.75%-42.74%-6.38%N/A
Brainstorm Cell Therapeutics Inc. stock logo
BCLI
Brainstorm Cell Therapeutics
-$11.62M-$1.65N/AN/AN/AN/AN/A-519.50%N/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
$9.28M$0.0622.00N/AN/AN/AN/AN/AN/A
Modular Medical, Inc. stock logo
MODD
Modular Medical
-$28.24M-$11.10N/AN/AN/AN/A-304.53%-220.88%9/2/2026 (Estimated)

Latest BASI, LUNA, MODD, and BCLI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Brainstorm Cell Therapeutics Inc. stock logo
BCLI
Brainstorm Cell Therapeutics
-$0.29-$0.35-$0.06N/AN/AN/A
8/14/2026Q1 2027
Modular Medical, Inc. stock logo
MODD
Modular Medical
N/A-$1.19N/A-$1.19N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bioanalytical Systems, Inc. stock logo
BASI
Bioanalytical Systems
N/AN/AN/AN/AN/A
Brainstorm Cell Therapeutics Inc. stock logo
BCLI
Brainstorm Cell Therapeutics
N/AN/AN/AN/AN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
N/AN/AN/AN/AN/A
Modular Medical, Inc. stock logo
MODD
Modular Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bioanalytical Systems, Inc. stock logo
BASI
Bioanalytical Systems
2.49
0.48
0.46
Brainstorm Cell Therapeutics Inc. stock logo
BCLI
Brainstorm Cell Therapeutics
N/A
0.21
0.21
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
N/AN/AN/A
Modular Medical, Inc. stock logo
MODD
Modular Medical
N/A
4.03
4.03

Institutional Ownership

CompanyInstitutional Ownership
Bioanalytical Systems, Inc. stock logo
BASI
Bioanalytical Systems
10.62%
Brainstorm Cell Therapeutics Inc. stock logo
BCLI
Brainstorm Cell Therapeutics
14.33%
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
87.46%
Modular Medical, Inc. stock logo
MODD
Modular Medical
27.47%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bioanalytical Systems, Inc. stock logo
BASI
Bioanalytical Systems
39711.13 millionN/ANot Optionable
Brainstorm Cell Therapeutics Inc. stock logo
BCLI
Brainstorm Cell Therapeutics
4011.38 million8.74 millionOptionable
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
39033.96 million31.38 millionNo Data
Modular Medical, Inc. stock logo
MODD
Modular Medical
205.98 million5.56 millionNot Optionable

Recent News About These Companies

Modular Medical (NASDAQ:MODD) Stock Rating Lowered by Wall Street Zen
Modular Medical (NASDAQ:MODD) Trading 8.4% Higher - Still a Buy?
Modular Medical launches Pivot tubeless insulin patch pump

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Bioanalytical Systems stock logo

Bioanalytical Systems NASDAQ:BASI

Bioanalytical Systems, Inc., doing business as Inotiv, provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. BioVaxys has an agreement with Inotiv to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.

Brainstorm Cell Therapeutics stock logo

Brainstorm Cell Therapeutics NASDAQ:BCLI

$1.41 +0.32 (+29.91%)
As of 03:59 PM Eastern

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of alzheimer's disease, as well as for other neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.

Luna Innovations stock logo

Luna Innovations NASDAQ:LUNA

$1.32 +0.02 (+1.54%)
As of 03:59 PM Eastern

Luna Innovations Incorporated provides fiber optic test, measurement, and control products worldwide. The company offers test and measurement equipment for fiber optic components and sub-assemblies; polarization control products, including components, modules, and instruments to measure, manage, and control polarization and group delay in fiber optic networks; tunable lasers; and single frequency lasers. It also provides ODiSI sensing solution, which provides distributed strain and temperature measurements; distributed temperature sensing system; hyperion sensing products; Terahertz Sensing Systems that provide precise single and multi-layer thickness, density, basis weight, and caliper thickness measurements; and distributed acoustic sensing products. The company primarily markets its fiber optic test, measurement, and control products to telecommunications companies, defense agencies, government system integrators, researchers, original equipment manufacturers, distributors, testing labs, and strategic partners directly, as well as through manufacturer representative organizations, partner and distribution channels, technical sales engineers, value added resellers, and independent sales representatives. Luna Innovations Incorporated was incorporated in 1990 and is headquartered in Roanoke, Virginia.

Modular Medical stock logo

Modular Medical NASDAQ:MODD

$3.03 +0.66 (+27.85%)
Closing price 04:00 PM Eastern
Extended Trading
$3.04 +0.01 (+0.33%)
As of 07:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.